It’s mid-November, and there’s a scurry at the food regulator’s office. Worried entrepreneurs haggle with a scientific panel in control of an all-important list. ‘Consider our ingredient’, they reason, for a mention in the list could mean a free pass with product approvals for all health supplements with the ingredient. For good.
But while they haggle, the CEO of HealthKart Sameer Maheshwari, seated comfortably in a conference room called Mary Kom, beams.